Merit Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
6,260
+833
| +15% | +$371K | 0.03% | 421 |
|
|
2025
Q1 | $2.63M | Buy |
5,427
+496
| +10% | +$240K | 0.04% | 353 |
|
|
2024
Q4 | $1.99M | Buy |
4,931
+2,155
| +78% | +$868K | 0.04% | 355 |
|
|
2024
Q3 | $1.29M | Sell |
2,776
-1,001
| -27% | -$466K | 0.03% | 355 |
|
|
2024
Q2 | $1.77M | Buy |
3,777
+342
| +10% | +$160K | 0.04% | 291 |
|
|
2024
Q1 | $1.38M | Buy |
3,435
+1,477
| +75% | +$592K | 0.03% | 332 |
|
|
2023
Q4 | $797K | Sell |
1,958
-1,698
| -46% | -$691K | 0.02% | 370 |
|
|
2023
Q3 | $1.27M | Sell |
3,656
-275
| -7% | -$95.6K | 0.04% | 281 |
|
|
2023
Q2 | $1.38M | Buy |
3,931
+2,297
| +141% | +$808K | 0.04% | 277 |
|
|
2023
Q1 | $515K | Buy |
+1,634
| New | +$515K | 0.02% | 390 |
|